PMC Links for Books (Select 5506746) - PMC

Result Filters

Links from Books

Items: 4

Select item 100674071.

Development of drugs targeting hypoxia‐inducible factor against tumor cells with VHL mutation: Story of 127 years

Hajime Takamori, Toshinari Yamasaki, Rui Kitadai, Yoji Andrew Minamishima, Eijiro Nakamura

Cancer Sci. 2023 Apr; 114(4): 1208–1217. Published online 2023 Jan 31. doi: 10.1111/cas.15728

PMCID:: PMC10067407

Abstract Article PDF–3.6M

Select item 96690932.

FDA Approval Summary: Belzutifan for von Hippel-Lindau disease associated tumors

Jaleh Fallah, Michael H Brave, Chana Weinstock, Gautam U Mehta, Diana Bradford, Haley Gittleman, Erik W. Bloomquist, Rosane Charlab, Salaheldin S Hamed, Claudia P Miller, Sarah E. Dorff, Wiley A Chambers, Bronwyn D Mixter, Jeannette Dinin, William F Pierce, Tiffany K Ricks, Shenghui Tang, Martha Donoghue, Richard Pazdur, Laleh Amiri-Kordestani, Amna Ibrahim, Julia A Beaver

Clin Cancer Res. Author manuscript; available in PMC 2023 May 14.

Published in final edited form as: Clin Cancer Res. 2022 Nov 14; 28(22): 4843–4848. doi: 10.1158/1078-0432.CCR-22-1054

PMCID:: PMC9669093

Abstract Article PDF–324K

Select item 92804043.

First clinical experience with belzutifan in von Hippel–Lindau disease associated CNS hemangioblastoma

Andrew Dhawan, David M Peereboom, Glen HJ Stevens

CNS Oncol. 2022 Sep; 11(3): CNS91. Published online 2022 Jul 12. doi: 10.2217/cns-2022-0008

PMCID:: PMC9280404

Abstract Article PDF–2.1M

Select item 92755154.

Belzutifan for Renal Cell Carcinoma in von Hippel–Lindau Disease

Eric Jonasch, Frede Donskov, Othon Iliopoulos, W. Kimryn Rathmell, Vivek K. Narayan, Benjamin L. Maughan, Stephane Oudard, Tobias Else, Jodi K. Maranchie, Sarah J. Welsh, Sanjay Thamake, Eric K. Park, Rodolfo F. Perini, W. Marston Linehan, Ramaprasad Srinivasan

N Engl J Med. Author manuscript; available in PMC 2022 Jul 12.

Published in final edited form as: N Engl J Med. 2021 Nov 25; 385(22): 2036–2046. doi: 10.1056/NEJMoa2103425